A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
This study is currently recruiting participants.
Study NCT00768339
Information provided by Aegera Therapeutics
First Received: October 6, 2008
Last Updated: June 2, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
